教養 - 藤田医科大学教育・研究業績

研究分野

ライフサイエンス / 内科学一般 /

論文

Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor.

Akihiro Abe Yukiya Yamamoto Akira Katsumi Hideyuki Yamamoto Akinao Okamoto Yoko Inaguma Chisako Iriyama Masutaka Tokuda Masataka Okamoto Nobuhiko Emi Akihiro Tomita

Cytogenetic and genome research 2020年6月 [査読有り]

Fusions of the Runt-related transcription factor 1 (RUNX1) with different partner genes have been associated with various hematological disorders. Interestingly, the C-terminally truncated form of RUNX1 and RUNX1 fusion proteins are similarly cons...

Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).

Abe A Yamamoto Y Katsumi A Okamoto A Tokuda M Inaguma Y Yamamoto K Yanada M Kanie T Tomita A Akatsuka Y Okamoto M Kameyama T Mayeda A Emi N

International Journal of Hematology 108(2) 208-212 2018年8月 [査読有り]

The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients

Akinao Okamoto Masamitsu Yanada Yoko Inaguma Masutaka Tokuda Satoko Morishima Tadaharu Kanie Yukiya Yamamoto Shuichi Mizuta Yoshiki Akatsuka Tetsushi Yoshikawa Yoshikazu Mizoguchi Shigeo Nakamura Masataka Okamoto Nobuhiko Emi

Hematological Oncology 35(1) 87-93 2017年3月 [査読有り]

Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin

Cancer Chemother Pharmacol. 78(2) 305-312 2016年8月 [査読有り]

In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition

C. Balachandran N. Emi Y. Arun N. Yamamoto V. Duraipandiyan Yoko Inaguma Akinao Okamoto S. Ignacimuthu N. A. Al-Dhabi P. T. Perumal

CHEMICO-BIOLOGICAL INTERACTIONS 249 23-35 2016年4月 [査読有り]

The present study investigated the anticancer activity of 2,3-dihydroxy-9,10-anthraquinone against different cancer cells such as MCF-7, COLO320, HepG-2, Skov-3, MOLM-14, NB-4, CEM, K562, Jurkat, HL-60, U937, IM-9 and Vero. 2,3-dihydroxy-9,10-anth...

MISC

12 3 4 5 >

血小板減少および腫瘍随伴性天疱瘡を合併したろ胞樹状細胞肉腫に対する外科切除併用化学療法の長期的効果

森谷遼馬入山智沙子杉浦一充岩井雅則岡本晃直稲熊容子徳田倍将山本幸也岡本昌隆冨田章裕

臨床血液 60(10) 1480-1480 2019年10月

ETV6の再構成による異所性遺伝子発現を認めた急性骨髄性白血病の二症例(Two cases of AML with ectopic gene expression resulting from the ETV6 rearrangements)

安部明弘山本幸也岡本晃直入山智沙子徳田倍将稲熊容子蟹江匡治冨田章裕赤塚美樹岡本昌隆亀山俊樹前田明恵美宣彦

臨床血液 59(9) 1642-1642 2018年9月

ALK陽性皮膚原発未分化大細胞リンパ腫の1例

渡邊総一郎岩田洋平沼田茂樹齋藤健太稲熊容子山本幸也渡邊薫岡本昌隆黒田誠杉浦一充

日本皮膚悪性腫瘍学会学術大会プログラム・抄録集 34回 120-120 2018年6月

再発急性骨髄性白血病において微小転座から複数のスプライシング産物を認めたRUNX1-GRIK2融合遺伝子(Multiple splicing transcripts from RUNX1-GRIK2 fusion in a cryptic translocation in a relapsed AML)

Abe Akihiro Yamamoto Yukiya Okamoto Akinao Tokuda Masutaka Inaguma Yoko Yanada Masamitsu Kanie Tadaharu Tomita Akihiro Akatsuka Yoshiki Okamoto Masataka Kameyama Toshiki Maeda Akira Emi Nobuhiko

臨床血液 58(9) 1603-1603 2017年9月

Rasburicase投与後の抗体産生の頻度と抗体価の推移に関する研究

安藤舞子赤塚美樹伊藤佳織徳田倍将稲熊容子岡本晃直蟹江匡治柳田正光山本幸也冨田章裕岡本昌隆山田成樹恵美宣彦

臨床血液 58(9) 1763-1763 2017年9月